Athena Global Investors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Athena Global Investors's LLY Position: Q1 2017 in Review
Athena Global Investors reduced its Eli Lilly (LLY) stake by 20% in Q1 2017, selling an estimated $197K and leaving 10,111 shares worth $850K. The position accounts for 2.55% of the portfolio, ranked #19.
Athena Global Investors first reported a position in LLY in Q1 2014 and has held it in 13 quarters since. The position peaked at $9.83M in Q3 2014. 1,250 funds tracked by Wall St. Rank hold LLY as of Q1 2017.
- Athena Global Investors held 10,111 shares of Eli Lilly worth $850K as of Q1 2017.
- Athena Global Investors sold 2,461 Eli Lilly shares in Q1 2017, an estimated $197K.
- Eli Lilly made up 2.55% of Athena Global Investors's portfolio in Q1 2017, its #19 holding.
- Athena Global Investors first reported a position in Eli Lilly in Q1 2014 and has held it in 13 quarters since.
- Athena Global Investors's Eli Lilly position peaked at $9.83M in Q3 2014.
- 1,250 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2017.
Based on Athena Global Investors's 13F filing for Q1 2017, filed 16 May 2017.